Navigation Links
Cost-effectiveness of HAART underestimated
Date:2/16/2012

Bohdan Nosyk and Julio Montaner of the British Columbia Centre for Excellence in HIV/AIDS in Vancouver, Canada argue in an Essay published in this week's PLoS Medicine that the cost-effectiveness of HAART roll out has been significantly underestimated, because economic analyses have not yet taken into account the beneficial impact of HAART on prevention of HIV transmission.

The authors comment: "the strategic value of expanded HIV testing and expansion of HAART coverage has dramatically increased. We believe this should open the door for wide-scale implementation of ''Seek, Test, Treat and Retain'' programs as a means to control HIV and AIDS-related morbidity, mortality, and transmission at once."


'/>"/>

Contact: Clare Weaver
press@plos.org
44-122-344-2834
Public Library of Science
Source:Eurekalert

Page: 1

Related medicine news :

1. Cost-effectiveness research needs to be considered in developing new medical technology
2. UNC physician authors editorial on cost-effectiveness study for colon cancer screening
3. Hospital Focus 5 Announces Contract with Connecticut Hospital to Improve Quality, Productivity and Cost-Effectiveness
4. Study Looks At Cost-Effectiveness of ECG in Hyperactive Kids
5. NIH-funded study finds early HAART during TB treatment boosts survival rate in co-infected people
6. Increased HAART coverage associated with 50 percent drop
7. Health risk from eating well-done meat may be underestimated
8. Gun Injuries to U.S. Kids Likely Underestimated: Study
9. Radiation rates for breast cancer may be underestimated, U-M study finds
10. Mayo researchers find mortality rates from liver diseases underestimated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Children born with cleft lip, cleft palate and ... appearance. , Patients can face serious airway, feeding, ... and psychological challenges, Laura Swibel Rosenthal, MD, of ... the June 2012 issue of Otolaryngologic Clinics ... patients with craniofacial syndromes is complex," Rosenthal and ...
(Date:5/22/2012)... Storrs HealthDay Reporter , , TUESDAY, May 22 ... sleep apnea, a common cause of snoring and daytime ... hazard associated with the condition -- the risk of ... the number of new cases of high blood pressure ... positive airway pressure therapy, or CPAP, for either about ...
(Date:5/22/2012)... LEXINGTON, Ky. (May 17, 2012) The University of ... million to study a deadly blood and bone marrow ... $5 million grant from the Edward P. Evans Foundation, ... research of myelodysplastic syndrome (MDS). , The Evans Foundation ... including three labs at UK, one at Cincinnati Children,s ...
(Date:5/22/2012)... that began last year when the U.S. Preventive Services ... regular prostate-cancer tests to healthy men continued this week ... they stuck to their guns, stating that a blood ... PSA test, causes more harm than good it ... treatments. , But many people simply don,t believe that ...
(Date:5/22/2012)... has tasked itself with the daunting challenge of ... , "Mobility to a child in a developing ... education, societal engagement versus no societal engagement and ... director of the Mercyhurst University Institute for Public ... recently traveled to Guanajuato, Mexico, with a team ...
Breaking Medicine News(10 mins):Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 2Health News:Sleep Apnea 'Mask' Might Also Help the Heart 3Health News:Sleep Apnea 'Mask' Might Also Help the Heart 4Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 2Health News:Markey receives $6.25 million to study deadly blood and bone marrow disease 3Health News:Psychological Science explains uproar over prostate-cancer screenings 2Health News:New initiative aims to increase mobility for disabled children worldwide 2
... since gene therapy pioneer William W. Hauswirth, Ph.D., and his ... virus that could safely deliver corrective genes into living animals. ... gene therapy to give sight to puppies born with a ... being tested for safety in people in a phase 1 ...
... even been reversed, experts warn , , MONDAY, Nov. 19 (HealthDay ... recent decades are starting to slip away for middle-aged Americans, ... said a report that used U.S. vital statistics data between ... The death rate from coronary disease fell by 52 percent ...
... the incidence of thyroid cancer is increasing. In this longitudinal ... and colleagues used the Ontario Cancer Registry to identify 7422 ... results show the jump in the incidence rate of this ... or an annual increase of 13% per year. , ...
... & Nephew,s,(NYSE: SNN ) (LSE: SN) Endoscopy Division ... LLC, a Boston-area investor group led by,Jonathan Donaldson and ... of the sale were not disclosed. The sale ... of Smith & Nephew,s overall Earnings Improvement Program, which ...
... Tips to Make Holiday Parties Merry and Safe for ... fun and excitement,associated with the holidays it,s sometimes easy ... in many ways. It can be a time when ... for,families. Teenagers or younger children may view these parties ...
... - Co-Author of the Eldercare Handbook - Issues Statement ... National Alliance of Caregiving, LOS ANGELES, Nov. 19 ... of caregiving being released today by the National Alliance,for ... hidden physical and,emotional costs experienced by caregivers. While anyone ...
Other Medicine News:Health News:Gene therapy safety trial for childhood blindness under way 2Health News:Gene therapy safety trial for childhood blindness under way 3Health News:Heart Death Rates Worsening for Middle-Aged Adults 2Health News:Heart Death Rates Worsening for Middle-Aged Adults 3Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 2Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 3Health News:Holidays Can Present Drinking Opportunities for Teens 2Health News:Holidays Can Present Drinking Opportunities for Teens 3
(Date:5/22/2012)... Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), ... largest ever set of orders for the MediPendant™ personal ... the user to speak and listen directly through the ... tranche of this order resulted in revenue to the ... this same customer through the end of the year, ...
(Date:5/22/2012)... -- ThermoGenesis Corp. (NASDAQ: KOOL ), a ... and administration of cell therapies, today said that it ... Platform (AXP) used for the processing of cord blood. ... in the country later this year. "We ... blood market through our efforts in China, Malaysia and ...
(Date:5/22/2012)... Surgical Corp. / surgicalinstruments.com has developed an ... and scrub techs who perform surgical instrument ... The resource center provides detailed pictures and ... used to protect and sterilize surgical instruments, ... heads, fiber optic light cables, diamond knives, ...
Breaking Medicine Technology:Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 2Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 3ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Millennium Surgical Corp. Develops Online Sterilization Resource Center 2Are All Those Handshakes at Graduation Hazardous to Your Health 3F 82134 1Are All Those Handshakes at Graduation Hazardous to Your Health 3F 82134 2Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 1Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 2Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 3Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 1Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 2Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 3Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 4Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 5Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 6Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 7Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 8Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 9
... 30 Peptimmune, Inc. a privately,held biotechnology ... Patent Number,7,381,790 (the ,790 patent) which protects ... copolymer for the treatment of autoimmune diseases., ... Ib multiple-ascending dose,double-blind, placebo-controlled randomized study in ...
... 30 Wound Care Innovations, LLC,a subsidiary of ... today an evidence based study with a NE ... wound care collagen,product, CellerateRx(R), on diabetic venous ulcers. ... Control and Prevention, diabetes now,affects nearly 24 million ...
Other Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2
Bookler Richardson Blade Set - for use with Bookler Universal Table Mounted Retractor Systems...
... word cohesive is a new term being used today ... the more liquid fill that may have been used ... not new science, this is not new technology ... to describe the sticking together nature of the gel. ...
Inquire...
Inquire...
Medicine Products: